nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelfinavir—ABCG2—lung cancer	0.205	0.706	CbGaD
Nelfinavir—ABCB1—lung cancer	0.0851	0.294	CbGaD
Nelfinavir—ABCG2—Topotecan—lung cancer	0.0254	0.05	CbGbCtD
Nelfinavir—ABCG2—Gefitinib—lung cancer	0.0232	0.0458	CbGbCtD
Nelfinavir—ABCG2—Teniposide—lung cancer	0.0225	0.0444	CbGbCtD
Nelfinavir—SLCO1B1—Irinotecan—lung cancer	0.0156	0.0308	CbGbCtD
Nelfinavir—ABCG2—Erlotinib—lung cancer	0.0137	0.0271	CbGbCtD
Nelfinavir—CYP3A5—Gefitinib—lung cancer	0.0129	0.0254	CbGbCtD
Nelfinavir—ABCG2—Paclitaxel—lung cancer	0.0126	0.0248	CbGbCtD
Nelfinavir—CYP3A5—Teniposide—lung cancer	0.0125	0.0246	CbGbCtD
Nelfinavir—ABCG2—Irinotecan—lung cancer	0.0124	0.0244	CbGbCtD
Nelfinavir—CYP2C19—Gefitinib—lung cancer	0.0104	0.0205	CbGbCtD
Nelfinavir—ABCG2—Cisplatin—lung cancer	0.0101	0.0199	CbGbCtD
Nelfinavir—CYP2C19—Teniposide—lung cancer	0.0101	0.0198	CbGbCtD
Nelfinavir—ABCG2—Etoposide—lung cancer	0.00993	0.0196	CbGbCtD
Nelfinavir—CYP3A7—Paclitaxel—lung cancer	0.00928	0.0183	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.00928	0.0183	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.00915	0.0181	CbGbCtD
Nelfinavir—CYP3A7—Irinotecan—lung cancer	0.00915	0.0181	CbGbCtD
Nelfinavir—ABCB1—Topotecan—lung cancer	0.00915	0.018	CbGbCtD
Nelfinavir—ABCG2—Docetaxel—lung cancer	0.00908	0.0179	CbGbCtD
Nelfinavir—SLCO1A2—Methotrexate—lung cancer	0.00875	0.0173	CbGbCtD
Nelfinavir—CYP2B6—Irinotecan—lung cancer	0.00872	0.0172	CbGbCtD
Nelfinavir—CYP2C9—Gefitinib—lung cancer	0.00862	0.017	CbGbCtD
Nelfinavir—ABCB1—Gefitinib—lung cancer	0.00837	0.0165	CbGbCtD
Nelfinavir—CYP2C9—Teniposide—lung cancer	0.00836	0.0165	CbGbCtD
Nelfinavir—SLCO1B1—Methotrexate—lung cancer	0.00826	0.0163	CbGbCtD
Nelfinavir—CYP2D6—Gefitinib—lung cancer	0.00789	0.0156	CbGbCtD
Nelfinavir—CYP3A5—Crizotinib—lung cancer	0.00788	0.0155	CbGbCtD
Nelfinavir—CYP3A5—Erlotinib—lung cancer	0.0076	0.015	CbGbCtD
Nelfinavir—CYP2B6—Cisplatin—lung cancer	0.00711	0.014	CbGbCtD
Nelfinavir—CYP3A5—Paclitaxel—lung cancer	0.00696	0.0137	CbGbCtD
Nelfinavir—CYP3A5—Irinotecan—lung cancer	0.00687	0.0135	CbGbCtD
Nelfinavir—ABCG2—Doxorubicin—lung cancer	0.00677	0.0134	CbGbCtD
Nelfinavir—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.00671	0.0132	CbGbCtD
Nelfinavir—CYP3A7—Docetaxel—lung cancer	0.00671	0.0132	CbGbCtD
Nelfinavir—ABCG2—Methotrexate—lung cancer	0.00656	0.0129	CbGbCtD
Nelfinavir—ABCB1—Vinorelbine—lung cancer	0.00645	0.0127	CbGbCtD
Nelfinavir—CYP2D6—Vinorelbine—lung cancer	0.00607	0.012	CbGbCtD
Nelfinavir—CYP1A2—Erlotinib—lung cancer	0.00566	0.0112	CbGbCtD
Nelfinavir—CYP3A5—Etoposide—lung cancer	0.0055	0.0108	CbGbCtD
Nelfinavir—CYP3A4—Topotecan—lung cancer	0.00548	0.0108	CbGbCtD
Nelfinavir—ABCB1—Crizotinib—lung cancer	0.00513	0.0101	CbGbCtD
Nelfinavir—CYP3A5—Docetaxel—lung cancer	0.00503	0.00992	CbGbCtD
Nelfinavir—CYP3A4—Gefitinib—lung cancer	0.00501	0.00989	CbGbCtD
Nelfinavir—ABCB1—Gemcitabine—lung cancer	0.00501	0.00989	CbGbCtD
Nelfinavir—ABCB1—Erlotinib—lung cancer	0.00495	0.00976	CbGbCtD
Nelfinavir—CYP3A4—Teniposide—lung cancer	0.00486	0.00959	CbGbCtD
Nelfinavir—CYP2B6—Doxorubicin—lung cancer	0.00476	0.00939	CbGbCtD
Nelfinavir—CYP2C9—Paclitaxel—lung cancer	0.00467	0.0092	CbGbCtD
Nelfinavir—CYP2D6—Erlotinib—lung cancer	0.00466	0.0092	CbGbCtD
Nelfinavir—ABCB1—Paclitaxel—lung cancer	0.00453	0.00893	CbGbCtD
Nelfinavir—ABCB1—Irinotecan—lung cancer	0.00447	0.00881	CbGbCtD
Nelfinavir—CYP1A2—Etoposide—lung cancer	0.00409	0.00807	CbGbCtD
Nelfinavir—ABCB1—Vinblastine—lung cancer	0.00397	0.00784	CbGbCtD
Nelfinavir—CYP3A4—Vinorelbine—lung cancer	0.00386	0.00762	CbGbCtD
Nelfinavir—CYP2C9—Cisplatin—lung cancer	0.00375	0.0074	CbGbCtD
Nelfinavir—CYP2D6—Vinblastine—lung cancer	0.00374	0.00738	CbGbCtD
Nelfinavir—ABCB1—Cisplatin—lung cancer	0.00364	0.00718	CbGbCtD
Nelfinavir—ABCB1—Etoposide—lung cancer	0.00358	0.00706	CbGbCtD
Nelfinavir—ABCB1—Docetaxel—lung cancer	0.00327	0.00646	CbGbCtD
Nelfinavir—CYP3A4—Crizotinib—lung cancer	0.00307	0.00606	CbGbCtD
Nelfinavir—CYP3A4—Erlotinib—lung cancer	0.00296	0.00585	CbGbCtD
Nelfinavir—CYP3A4—Paclitaxel—lung cancer	0.00271	0.00535	CbGbCtD
Nelfinavir—CYP3A4—Irinotecan—lung cancer	0.00268	0.00528	CbGbCtD
Nelfinavir—ABCB1—Doxorubicin—lung cancer	0.00244	0.00481	CbGbCtD
Nelfinavir—CYP3A4—Vinblastine—lung cancer	0.00238	0.00469	CbGbCtD
Nelfinavir—ABCB1—Methotrexate—lung cancer	0.00236	0.00466	CbGbCtD
Nelfinavir—CYP2D6—Doxorubicin—lung cancer	0.0023	0.00454	CbGbCtD
Nelfinavir—CYP3A4—Etoposide—lung cancer	0.00214	0.00423	CbGbCtD
Nelfinavir—CYP3A4—Docetaxel—lung cancer	0.00196	0.00387	CbGbCtD
Nelfinavir—CYP3A4—Doxorubicin—lung cancer	0.00146	0.00288	CbGbCtD
Nelfinavir—Saquinavir—ABCG2—lung cancer	0.000503	0.415	CrCbGaD
Nelfinavir—Indinavir—ABCB1—lung cancer	0.00028	0.231	CrCbGaD
Nelfinavir—Saquinavir—ALB—lung cancer	0.000219	0.181	CrCbGaD
Nelfinavir—Saquinavir—ABCB1—lung cancer	0.000209	0.173	CrCbGaD
Nelfinavir—Muscle spasms—Docetaxel—lung cancer	8.1e-05	0.000652	CcSEcCtD
Nelfinavir—Liver function test abnormal—Doxorubicin—lung cancer	8.06e-05	0.000649	CcSEcCtD
Nelfinavir—Dyspnoea—Cisplatin—lung cancer	8.05e-05	0.000648	CcSEcCtD
Nelfinavir—Skin disorder—Etoposide—lung cancer	8.04e-05	0.000647	CcSEcCtD
Nelfinavir—Hyperhidrosis—Etoposide—lung cancer	8e-05	0.000644	CcSEcCtD
Nelfinavir—Feeling abnormal—Gemcitabine—lung cancer	7.98e-05	0.000643	CcSEcCtD
Nelfinavir—Dizziness—Vinorelbine—lung cancer	7.98e-05	0.000642	CcSEcCtD
Nelfinavir—Abdominal pain upper—Doxorubicin—lung cancer	7.97e-05	0.000642	CcSEcCtD
Nelfinavir—Thrombocytopenia—Paclitaxel—lung cancer	7.94e-05	0.00064	CcSEcCtD
Nelfinavir—Anorexia—Etoposide—lung cancer	7.89e-05	0.000635	CcSEcCtD
Nelfinavir—Skin disorder—Paclitaxel—lung cancer	7.88e-05	0.000634	CcSEcCtD
Nelfinavir—Body temperature increased—Irinotecan—lung cancer	7.86e-05	0.000633	CcSEcCtD
Nelfinavir—Abdominal pain—Irinotecan—lung cancer	7.86e-05	0.000633	CcSEcCtD
Nelfinavir—Aspartate aminotransferase increased—Doxorubicin—lung cancer	7.86e-05	0.000633	CcSEcCtD
Nelfinavir—Decreased appetite—Cisplatin—lung cancer	7.85e-05	0.000632	CcSEcCtD
Nelfinavir—Hyperhidrosis—Paclitaxel—lung cancer	7.84e-05	0.000631	CcSEcCtD
Nelfinavir—Pneumonia—Methotrexate—lung cancer	7.82e-05	0.000629	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Cisplatin—lung cancer	7.8e-05	0.000628	CcSEcCtD
Nelfinavir—Anaemia—Docetaxel—lung cancer	7.79e-05	0.000627	CcSEcCtD
Nelfinavir—Anorexia—Paclitaxel—lung cancer	7.73e-05	0.000623	CcSEcCtD
Nelfinavir—Pain—Cisplatin—lung cancer	7.72e-05	0.000622	CcSEcCtD
Nelfinavir—Muscular weakness—Doxorubicin—lung cancer	7.7e-05	0.00062	CcSEcCtD
Nelfinavir—Alanine aminotransferase increased—Doxorubicin—lung cancer	7.7e-05	0.00062	CcSEcCtD
Nelfinavir—Vomiting—Vinorelbine—lung cancer	7.67e-05	0.000617	CcSEcCtD
Nelfinavir—Body temperature increased—Gemcitabine—lung cancer	7.66e-05	0.000617	CcSEcCtD
Nelfinavir—Rash—Vinorelbine—lung cancer	7.6e-05	0.000612	CcSEcCtD
Nelfinavir—Dermatitis—Vinorelbine—lung cancer	7.6e-05	0.000612	CcSEcCtD
Nelfinavir—Abdominal distension—Doxorubicin—lung cancer	7.6e-05	0.000612	CcSEcCtD
Nelfinavir—Stomatitis—Methotrexate—lung cancer	7.57e-05	0.00061	CcSEcCtD
Nelfinavir—Headache—Vinorelbine—lung cancer	7.56e-05	0.000608	CcSEcCtD
Nelfinavir—Leukopenia—Docetaxel—lung cancer	7.54e-05	0.000607	CcSEcCtD
Nelfinavir—Sweating—Methotrexate—lung cancer	7.45e-05	0.0006	CcSEcCtD
Nelfinavir—Feeling abnormal—Cisplatin—lung cancer	7.44e-05	0.000599	CcSEcCtD
Nelfinavir—Paraesthesia—Etoposide—lung cancer	7.43e-05	0.000598	CcSEcCtD
Nelfinavir—Pancreatitis—Doxorubicin—lung cancer	7.4e-05	0.000596	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Paclitaxel—lung cancer	7.39e-05	0.000595	CcSEcCtD
Nelfinavir—Dyspnoea—Etoposide—lung cancer	7.38e-05	0.000594	CcSEcCtD
Nelfinavir—Somnolence—Etoposide—lung cancer	7.36e-05	0.000592	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Methotrexate—lung cancer	7.35e-05	0.000592	CcSEcCtD
Nelfinavir—Insomnia—Paclitaxel—lung cancer	7.34e-05	0.000591	CcSEcCtD
Nelfinavir—Epistaxis—Methotrexate—lung cancer	7.33e-05	0.00059	CcSEcCtD
Nelfinavir—Hypersensitivity—Irinotecan—lung cancer	7.33e-05	0.00059	CcSEcCtD
Nelfinavir—Convulsion—Docetaxel—lung cancer	7.3e-05	0.000588	CcSEcCtD
Nelfinavir—Paraesthesia—Paclitaxel—lung cancer	7.28e-05	0.000587	CcSEcCtD
Nelfinavir—Dyspnoea—Paclitaxel—lung cancer	7.23e-05	0.000582	CcSEcCtD
Nelfinavir—Somnolence—Paclitaxel—lung cancer	7.21e-05	0.000581	CcSEcCtD
Nelfinavir—Decreased appetite—Etoposide—lung cancer	7.19e-05	0.000579	CcSEcCtD
Nelfinavir—Arthralgia—Docetaxel—lung cancer	7.17e-05	0.000578	CcSEcCtD
Nelfinavir—Myalgia—Docetaxel—lung cancer	7.17e-05	0.000578	CcSEcCtD
Nelfinavir—Nausea—Vinorelbine—lung cancer	7.16e-05	0.000577	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Etoposide—lung cancer	7.14e-05	0.000575	CcSEcCtD
Nelfinavir—Dyspepsia—Paclitaxel—lung cancer	7.14e-05	0.000575	CcSEcCtD
Nelfinavir—Body temperature increased—Cisplatin—lung cancer	7.14e-05	0.000575	CcSEcCtD
Nelfinavir—Asthenia—Irinotecan—lung cancer	7.14e-05	0.000575	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	7.12e-05	0.000574	CcSEcCtD
Nelfinavir—Pain—Etoposide—lung cancer	7.08e-05	0.00057	CcSEcCtD
Nelfinavir—Neutropenia—Doxorubicin—lung cancer	7.06e-05	0.000568	CcSEcCtD
Nelfinavir—Decreased appetite—Paclitaxel—lung cancer	7.05e-05	0.000568	CcSEcCtD
Nelfinavir—Haemoglobin—Methotrexate—lung cancer	7.01e-05	0.000565	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Paclitaxel—lung cancer	7e-05	0.000564	CcSEcCtD
Nelfinavir—Haemorrhage—Methotrexate—lung cancer	6.98e-05	0.000562	CcSEcCtD
Nelfinavir—Hepatitis—Methotrexate—lung cancer	6.98e-05	0.000562	CcSEcCtD
Nelfinavir—Asthenia—Gemcitabine—lung cancer	6.95e-05	0.00056	CcSEcCtD
Nelfinavir—Pain—Paclitaxel—lung cancer	6.94e-05	0.000559	CcSEcCtD
Nelfinavir—Pharyngitis—Methotrexate—lung cancer	6.92e-05	0.000557	CcSEcCtD
Nelfinavir—Oedema—Docetaxel—lung cancer	6.88e-05	0.000554	CcSEcCtD
Nelfinavir—Pruritus—Gemcitabine—lung cancer	6.86e-05	0.000552	CcSEcCtD
Nelfinavir—Feeling abnormal—Etoposide—lung cancer	6.82e-05	0.000549	CcSEcCtD
Nelfinavir—Hyperglycaemia—Doxorubicin—lung cancer	6.81e-05	0.000548	CcSEcCtD
Nelfinavir—Diarrhoea—Irinotecan—lung cancer	6.81e-05	0.000548	CcSEcCtD
Nelfinavir—Pneumonia—Doxorubicin—lung cancer	6.77e-05	0.000545	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Etoposide—lung cancer	6.77e-05	0.000545	CcSEcCtD
Nelfinavir—Thrombocytopenia—Docetaxel—lung cancer	6.73e-05	0.000542	CcSEcCtD
Nelfinavir—Feeling abnormal—Paclitaxel—lung cancer	6.69e-05	0.000538	CcSEcCtD
Nelfinavir—Skin disorder—Docetaxel—lung cancer	6.68e-05	0.000538	CcSEcCtD
Nelfinavir—Hypersensitivity—Cisplatin—lung cancer	6.65e-05	0.000536	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Paclitaxel—lung cancer	6.63e-05	0.000534	CcSEcCtD
Nelfinavir—Diarrhoea—Gemcitabine—lung cancer	6.63e-05	0.000534	CcSEcCtD
Nelfinavir—Erythema multiforme—Methotrexate—lung cancer	6.6e-05	0.000531	CcSEcCtD
Nelfinavir—Dizziness—Irinotecan—lung cancer	6.58e-05	0.00053	CcSEcCtD
Nelfinavir—Urticaria—Etoposide—lung cancer	6.57e-05	0.000529	CcSEcCtD
Nelfinavir—Stomatitis—Doxorubicin—lung cancer	6.56e-05	0.000528	CcSEcCtD
Nelfinavir—Jaundice—Doxorubicin—lung cancer	6.56e-05	0.000528	CcSEcCtD
Nelfinavir—Anorexia—Docetaxel—lung cancer	6.55e-05	0.000528	CcSEcCtD
Nelfinavir—Body temperature increased—Etoposide—lung cancer	6.54e-05	0.000527	CcSEcCtD
Nelfinavir—Abdominal pain—Etoposide—lung cancer	6.54e-05	0.000527	CcSEcCtD
Nelfinavir—Eye disorder—Methotrexate—lung cancer	6.52e-05	0.000525	CcSEcCtD
Nelfinavir—Asthenia—Cisplatin—lung cancer	6.48e-05	0.000522	CcSEcCtD
Nelfinavir—Sweating—Doxorubicin—lung cancer	6.45e-05	0.000519	CcSEcCtD
Nelfinavir—Urticaria—Paclitaxel—lung cancer	6.44e-05	0.000519	CcSEcCtD
Nelfinavir—Abdominal pain—Paclitaxel—lung cancer	6.41e-05	0.000516	CcSEcCtD
Nelfinavir—Body temperature increased—Paclitaxel—lung cancer	6.41e-05	0.000516	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Doxorubicin—lung cancer	6.36e-05	0.000512	CcSEcCtD
Nelfinavir—Epistaxis—Doxorubicin—lung cancer	6.35e-05	0.000511	CcSEcCtD
Nelfinavir—Angiopathy—Methotrexate—lung cancer	6.33e-05	0.00051	CcSEcCtD
Nelfinavir—Vomiting—Irinotecan—lung cancer	6.32e-05	0.000509	CcSEcCtD
Nelfinavir—Sinusitis—Doxorubicin—lung cancer	6.31e-05	0.000508	CcSEcCtD
Nelfinavir—Immune system disorder—Methotrexate—lung cancer	6.3e-05	0.000507	CcSEcCtD
Nelfinavir—Rash—Irinotecan—lung cancer	6.27e-05	0.000505	CcSEcCtD
Nelfinavir—Dermatitis—Irinotecan—lung cancer	6.27e-05	0.000505	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Docetaxel—lung cancer	6.26e-05	0.000504	CcSEcCtD
Nelfinavir—Headache—Irinotecan—lung cancer	6.23e-05	0.000502	CcSEcCtD
Nelfinavir—Insomnia—Docetaxel—lung cancer	6.22e-05	0.000501	CcSEcCtD
Nelfinavir—Diarrhoea—Cisplatin—lung cancer	6.18e-05	0.000498	CcSEcCtD
Nelfinavir—Paraesthesia—Docetaxel—lung cancer	6.17e-05	0.000497	CcSEcCtD
Nelfinavir—Vomiting—Gemcitabine—lung cancer	6.16e-05	0.000496	CcSEcCtD
Nelfinavir—Dyspnoea—Docetaxel—lung cancer	6.13e-05	0.000494	CcSEcCtD
Nelfinavir—Somnolence—Docetaxel—lung cancer	6.11e-05	0.000492	CcSEcCtD
Nelfinavir—Rash—Gemcitabine—lung cancer	6.11e-05	0.000492	CcSEcCtD
Nelfinavir—Dermatitis—Gemcitabine—lung cancer	6.1e-05	0.000491	CcSEcCtD
Nelfinavir—Hypersensitivity—Etoposide—lung cancer	6.1e-05	0.000491	CcSEcCtD
Nelfinavir—Erythema—Methotrexate—lung cancer	6.07e-05	0.000489	CcSEcCtD
Nelfinavir—Malnutrition—Methotrexate—lung cancer	6.07e-05	0.000489	CcSEcCtD
Nelfinavir—Haemoglobin—Doxorubicin—lung cancer	6.07e-05	0.000489	CcSEcCtD
Nelfinavir—Headache—Gemcitabine—lung cancer	6.07e-05	0.000489	CcSEcCtD
Nelfinavir—Rhinitis—Doxorubicin—lung cancer	6.06e-05	0.000488	CcSEcCtD
Nelfinavir—Dyspepsia—Docetaxel—lung cancer	6.05e-05	0.000487	CcSEcCtD
Nelfinavir—Hepatitis—Doxorubicin—lung cancer	6.04e-05	0.000486	CcSEcCtD
Nelfinavir—Haemorrhage—Doxorubicin—lung cancer	6.04e-05	0.000486	CcSEcCtD
Nelfinavir—Pharyngitis—Doxorubicin—lung cancer	6e-05	0.000483	CcSEcCtD
Nelfinavir—Decreased appetite—Docetaxel—lung cancer	5.98e-05	0.000481	CcSEcCtD
Nelfinavir—Hypersensitivity—Paclitaxel—lung cancer	5.98e-05	0.000481	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Docetaxel—lung cancer	5.94e-05	0.000478	CcSEcCtD
Nelfinavir—Asthenia—Etoposide—lung cancer	5.94e-05	0.000478	CcSEcCtD
Nelfinavir—Connective tissue disorder—Doxorubicin—lung cancer	5.94e-05	0.000478	CcSEcCtD
Nelfinavir—Nausea—Irinotecan—lung cancer	5.91e-05	0.000476	CcSEcCtD
Nelfinavir—Pain—Docetaxel—lung cancer	5.88e-05	0.000473	CcSEcCtD
Nelfinavir—Back pain—Methotrexate—lung cancer	5.87e-05	0.000473	CcSEcCtD
Nelfinavir—Pruritus—Etoposide—lung cancer	5.85e-05	0.000471	CcSEcCtD
Nelfinavir—Asthenia—Paclitaxel—lung cancer	5.82e-05	0.000469	CcSEcCtD
Nelfinavir—Nausea—Gemcitabine—lung cancer	5.76e-05	0.000463	CcSEcCtD
Nelfinavir—Vomiting—Cisplatin—lung cancer	5.74e-05	0.000462	CcSEcCtD
Nelfinavir—Pruritus—Paclitaxel—lung cancer	5.74e-05	0.000462	CcSEcCtD
Nelfinavir—Erythema multiforme—Doxorubicin—lung cancer	5.71e-05	0.00046	CcSEcCtD
Nelfinavir—Rash—Cisplatin—lung cancer	5.69e-05	0.000459	CcSEcCtD
Nelfinavir—Dermatitis—Cisplatin—lung cancer	5.69e-05	0.000458	CcSEcCtD
Nelfinavir—Feeling abnormal—Docetaxel—lung cancer	5.67e-05	0.000456	CcSEcCtD
Nelfinavir—Diarrhoea—Etoposide—lung cancer	5.66e-05	0.000456	CcSEcCtD
Nelfinavir—Eye disorder—Doxorubicin—lung cancer	5.64e-05	0.000455	CcSEcCtD
Nelfinavir—Ill-defined disorder—Methotrexate—lung cancer	5.63e-05	0.000454	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Docetaxel—lung cancer	5.62e-05	0.000453	CcSEcCtD
Nelfinavir—Anaemia—Methotrexate—lung cancer	5.61e-05	0.000452	CcSEcCtD
Nelfinavir—Diarrhoea—Paclitaxel—lung cancer	5.55e-05	0.000447	CcSEcCtD
Nelfinavir—Angiopathy—Doxorubicin—lung cancer	5.48e-05	0.000441	CcSEcCtD
Nelfinavir—Malaise—Methotrexate—lung cancer	5.48e-05	0.000441	CcSEcCtD
Nelfinavir—Dizziness—Etoposide—lung cancer	5.47e-05	0.000441	CcSEcCtD
Nelfinavir—Immune system disorder—Doxorubicin—lung cancer	5.46e-05	0.000439	CcSEcCtD
Nelfinavir—Abdominal pain—Docetaxel—lung cancer	5.44e-05	0.000438	CcSEcCtD
Nelfinavir—Body temperature increased—Docetaxel—lung cancer	5.44e-05	0.000438	CcSEcCtD
Nelfinavir—Leukopenia—Methotrexate—lung cancer	5.44e-05	0.000438	CcSEcCtD
Nelfinavir—Dizziness—Paclitaxel—lung cancer	5.36e-05	0.000432	CcSEcCtD
Nelfinavir—Nausea—Cisplatin—lung cancer	5.36e-05	0.000432	CcSEcCtD
Nelfinavir—Convulsion—Methotrexate—lung cancer	5.26e-05	0.000424	CcSEcCtD
Nelfinavir—Vomiting—Etoposide—lung cancer	5.26e-05	0.000424	CcSEcCtD
Nelfinavir—Erythema—Doxorubicin—lung cancer	5.26e-05	0.000423	CcSEcCtD
Nelfinavir—Malnutrition—Doxorubicin—lung cancer	5.26e-05	0.000423	CcSEcCtD
Nelfinavir—Rash—Etoposide—lung cancer	5.22e-05	0.00042	CcSEcCtD
Nelfinavir—Dermatitis—Etoposide—lung cancer	5.21e-05	0.00042	CcSEcCtD
Nelfinavir—Headache—Etoposide—lung cancer	5.18e-05	0.000417	CcSEcCtD
Nelfinavir—Flatulence—Doxorubicin—lung cancer	5.18e-05	0.000417	CcSEcCtD
Nelfinavir—Myalgia—Methotrexate—lung cancer	5.17e-05	0.000416	CcSEcCtD
Nelfinavir—Arthralgia—Methotrexate—lung cancer	5.17e-05	0.000416	CcSEcCtD
Nelfinavir—Vomiting—Paclitaxel—lung cancer	5.16e-05	0.000415	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	5.13e-05	0.000413	CcSEcCtD
Nelfinavir—Rash—Paclitaxel—lung cancer	5.12e-05	0.000412	CcSEcCtD
Nelfinavir—Dermatitis—Paclitaxel—lung cancer	5.11e-05	0.000411	CcSEcCtD
Nelfinavir—Discomfort—Methotrexate—lung cancer	5.11e-05	0.000411	CcSEcCtD
Nelfinavir—Back pain—Doxorubicin—lung cancer	5.09e-05	0.00041	CcSEcCtD
Nelfinavir—Headache—Paclitaxel—lung cancer	5.08e-05	0.000409	CcSEcCtD
Nelfinavir—Hypersensitivity—Docetaxel—lung cancer	5.07e-05	0.000408	CcSEcCtD
Nelfinavir—Muscle spasms—Doxorubicin—lung cancer	5.06e-05	0.000407	CcSEcCtD
Nelfinavir—Asthenia—Docetaxel—lung cancer	4.93e-05	0.000397	CcSEcCtD
Nelfinavir—Nausea—Etoposide—lung cancer	4.91e-05	0.000396	CcSEcCtD
Nelfinavir—Ill-defined disorder—Doxorubicin—lung cancer	4.88e-05	0.000393	CcSEcCtD
Nelfinavir—Pruritus—Docetaxel—lung cancer	4.86e-05	0.000392	CcSEcCtD
Nelfinavir—Anaemia—Doxorubicin—lung cancer	4.86e-05	0.000391	CcSEcCtD
Nelfinavir—Thrombocytopenia—Methotrexate—lung cancer	4.85e-05	0.000391	CcSEcCtD
Nelfinavir—Agitation—Doxorubicin—lung cancer	4.83e-05	0.000389	CcSEcCtD
Nelfinavir—Nausea—Paclitaxel—lung cancer	4.82e-05	0.000388	CcSEcCtD
Nelfinavir—Skin disorder—Methotrexate—lung cancer	4.81e-05	0.000388	CcSEcCtD
Nelfinavir—Hyperhidrosis—Methotrexate—lung cancer	4.79e-05	0.000386	CcSEcCtD
Nelfinavir—Malaise—Doxorubicin—lung cancer	4.74e-05	0.000382	CcSEcCtD
Nelfinavir—Anorexia—Methotrexate—lung cancer	4.72e-05	0.00038	CcSEcCtD
Nelfinavir—Leukopenia—Doxorubicin—lung cancer	4.71e-05	0.000379	CcSEcCtD
Nelfinavir—Diarrhoea—Docetaxel—lung cancer	4.7e-05	0.000379	CcSEcCtD
Nelfinavir—Convulsion—Doxorubicin—lung cancer	4.56e-05	0.000367	CcSEcCtD
Nelfinavir—Dizziness—Docetaxel—lung cancer	4.55e-05	0.000366	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Methotrexate—lung cancer	4.52e-05	0.000364	CcSEcCtD
Nelfinavir—Insomnia—Methotrexate—lung cancer	4.48e-05	0.000361	CcSEcCtD
Nelfinavir—Myalgia—Doxorubicin—lung cancer	4.48e-05	0.00036	CcSEcCtD
Nelfinavir—Arthralgia—Doxorubicin—lung cancer	4.48e-05	0.00036	CcSEcCtD
Nelfinavir—Anxiety—Doxorubicin—lung cancer	4.46e-05	0.000359	CcSEcCtD
Nelfinavir—Paraesthesia—Methotrexate—lung cancer	4.45e-05	0.000358	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	4.45e-05	0.000358	CcSEcCtD
Nelfinavir—Discomfort—Doxorubicin—lung cancer	4.42e-05	0.000356	CcSEcCtD
Nelfinavir—Dyspnoea—Methotrexate—lung cancer	4.42e-05	0.000356	CcSEcCtD
Nelfinavir—Somnolence—Methotrexate—lung cancer	4.41e-05	0.000355	CcSEcCtD
Nelfinavir—Vomiting—Docetaxel—lung cancer	4.37e-05	0.000352	CcSEcCtD
Nelfinavir—Dyspepsia—Methotrexate—lung cancer	4.36e-05	0.000351	CcSEcCtD
Nelfinavir—Rash—Docetaxel—lung cancer	4.34e-05	0.000349	CcSEcCtD
Nelfinavir—Dermatitis—Docetaxel—lung cancer	4.33e-05	0.000349	CcSEcCtD
Nelfinavir—Decreased appetite—Methotrexate—lung cancer	4.31e-05	0.000347	CcSEcCtD
Nelfinavir—Headache—Docetaxel—lung cancer	4.31e-05	0.000347	CcSEcCtD
Nelfinavir—Oedema—Doxorubicin—lung cancer	4.29e-05	0.000346	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Methotrexate—lung cancer	4.28e-05	0.000345	CcSEcCtD
Nelfinavir—Pain—Methotrexate—lung cancer	4.24e-05	0.000341	CcSEcCtD
Nelfinavir—Thrombocytopenia—Doxorubicin—lung cancer	4.2e-05	0.000338	CcSEcCtD
Nelfinavir—Skin disorder—Doxorubicin—lung cancer	4.17e-05	0.000336	CcSEcCtD
Nelfinavir—Hyperhidrosis—Doxorubicin—lung cancer	4.15e-05	0.000334	CcSEcCtD
Nelfinavir—Anorexia—Doxorubicin—lung cancer	4.09e-05	0.000329	CcSEcCtD
Nelfinavir—Nausea—Docetaxel—lung cancer	4.08e-05	0.000329	CcSEcCtD
Nelfinavir—Feeling abnormal—Methotrexate—lung cancer	4.08e-05	0.000329	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Methotrexate—lung cancer	4.05e-05	0.000326	CcSEcCtD
Nelfinavir—Urticaria—Methotrexate—lung cancer	3.94e-05	0.000317	CcSEcCtD
Nelfinavir—Body temperature increased—Methotrexate—lung cancer	3.92e-05	0.000315	CcSEcCtD
Nelfinavir—Abdominal pain—Methotrexate—lung cancer	3.92e-05	0.000315	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Doxorubicin—lung cancer	3.91e-05	0.000315	CcSEcCtD
Nelfinavir—Insomnia—Doxorubicin—lung cancer	3.88e-05	0.000313	CcSEcCtD
Nelfinavir—Paraesthesia—Doxorubicin—lung cancer	3.85e-05	0.00031	CcSEcCtD
Nelfinavir—Dyspnoea—Doxorubicin—lung cancer	3.83e-05	0.000308	CcSEcCtD
Nelfinavir—Somnolence—Doxorubicin—lung cancer	3.82e-05	0.000307	CcSEcCtD
Nelfinavir—Dyspepsia—Doxorubicin—lung cancer	3.78e-05	0.000304	CcSEcCtD
Nelfinavir—Decreased appetite—Doxorubicin—lung cancer	3.73e-05	0.0003	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Doxorubicin—lung cancer	3.7e-05	0.000298	CcSEcCtD
Nelfinavir—Pain—Doxorubicin—lung cancer	3.67e-05	0.000295	CcSEcCtD
Nelfinavir—Hypersensitivity—Methotrexate—lung cancer	3.65e-05	0.000294	CcSEcCtD
Nelfinavir—Asthenia—Methotrexate—lung cancer	3.56e-05	0.000286	CcSEcCtD
Nelfinavir—Feeling abnormal—Doxorubicin—lung cancer	3.54e-05	0.000285	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Doxorubicin—lung cancer	3.51e-05	0.000283	CcSEcCtD
Nelfinavir—Pruritus—Methotrexate—lung cancer	3.51e-05	0.000282	CcSEcCtD
Nelfinavir—Urticaria—Doxorubicin—lung cancer	3.41e-05	0.000274	CcSEcCtD
Nelfinavir—Body temperature increased—Doxorubicin—lung cancer	3.39e-05	0.000273	CcSEcCtD
Nelfinavir—Abdominal pain—Doxorubicin—lung cancer	3.39e-05	0.000273	CcSEcCtD
Nelfinavir—Diarrhoea—Methotrexate—lung cancer	3.39e-05	0.000273	CcSEcCtD
Nelfinavir—Dizziness—Methotrexate—lung cancer	3.28e-05	0.000264	CcSEcCtD
Nelfinavir—Hypersensitivity—Doxorubicin—lung cancer	3.16e-05	0.000255	CcSEcCtD
Nelfinavir—Vomiting—Methotrexate—lung cancer	3.15e-05	0.000254	CcSEcCtD
Nelfinavir—Rash—Methotrexate—lung cancer	3.12e-05	0.000252	CcSEcCtD
Nelfinavir—Dermatitis—Methotrexate—lung cancer	3.12e-05	0.000251	CcSEcCtD
Nelfinavir—Headache—Methotrexate—lung cancer	3.1e-05	0.00025	CcSEcCtD
Nelfinavir—Asthenia—Doxorubicin—lung cancer	3.08e-05	0.000248	CcSEcCtD
Nelfinavir—Pruritus—Doxorubicin—lung cancer	3.04e-05	0.000244	CcSEcCtD
Nelfinavir—Nausea—Methotrexate—lung cancer	2.94e-05	0.000237	CcSEcCtD
Nelfinavir—Diarrhoea—Doxorubicin—lung cancer	2.94e-05	0.000236	CcSEcCtD
Nelfinavir—Dizziness—Doxorubicin—lung cancer	2.84e-05	0.000228	CcSEcCtD
Nelfinavir—Vomiting—Doxorubicin—lung cancer	2.73e-05	0.00022	CcSEcCtD
Nelfinavir—Rash—Doxorubicin—lung cancer	2.71e-05	0.000218	CcSEcCtD
Nelfinavir—Dermatitis—Doxorubicin—lung cancer	2.7e-05	0.000218	CcSEcCtD
Nelfinavir—Headache—Doxorubicin—lung cancer	2.69e-05	0.000216	CcSEcCtD
Nelfinavir—Nausea—Doxorubicin—lung cancer	2.55e-05	0.000205	CcSEcCtD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	4.25e-06	5.46e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PIK3CB—lung cancer	4.24e-06	5.45e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—GSTM1—lung cancer	4.23e-06	5.43e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CYP2E1—lung cancer	4.21e-06	5.41e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ADCY1—lung cancer	4.2e-06	5.4e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ABCG2—lung cancer	4.2e-06	5.4e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PTGS2—lung cancer	4.2e-06	5.4e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	4.18e-06	5.37e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GSTA2—lung cancer	4.17e-06	5.36e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—POMC—lung cancer	4.17e-06	5.36e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—NQO1—lung cancer	4.16e-06	5.35e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PIK3CD—lung cancer	4.16e-06	5.35e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	4.14e-06	5.32e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—POMC—lung cancer	4.14e-06	5.31e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ENO2—lung cancer	4.12e-06	5.3e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—HPGDS—lung cancer	4.12e-06	5.3e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—ALB—lung cancer	4.11e-06	5.28e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CYP1A1—lung cancer	4.1e-06	5.27e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PPP2R1B—lung cancer	4.1e-06	5.27e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—ERCC2—lung cancer	4.07e-06	5.23e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—CREBBP—lung cancer	4.06e-06	5.22e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	4.04e-06	5.2e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PIK3CG—lung cancer	4.04e-06	5.19e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—CREBBP—lung cancer	4.03e-06	5.18e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GSTA1—lung cancer	4.03e-06	5.17e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CYP1A1—lung cancer	4.01e-06	5.15e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GSTT1—lung cancer	4e-06	5.14e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ABCC3—lung cancer	3.98e-06	5.12e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—ERCC2—lung cancer	3.98e-06	5.11e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	3.97e-06	5.1e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CYP2E1—lung cancer	3.97e-06	5.1e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GCLC—lung cancer	3.95e-06	5.08e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYP2A6—lung cancer	3.95e-06	5.08e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	3.94e-06	5.06e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CYP2E1—lung cancer	3.93e-06	5.05e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—NQO1—lung cancer	3.92e-06	5.04e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—NQO1—lung cancer	3.89e-06	5e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—AKR1C1—lung cancer	3.86e-06	4.95e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PIK3CD—lung cancer	3.85e-06	4.95e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—POMC—lung cancer	3.85e-06	4.94e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—STK11—lung cancer	3.85e-06	4.94e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PIK3CD—lung cancer	3.82e-06	4.91e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.81e-06	4.89e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—ALB—lung cancer	3.8e-06	4.89e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.77e-06	4.85e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—ALB—lung cancer	3.77e-06	4.84e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—STK11—lung cancer	3.75e-06	4.82e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—CREBBP—lung cancer	3.75e-06	4.82e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ENO1—lung cancer	3.75e-06	4.82e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—UGT1A1—lung cancer	3.74e-06	4.81e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	3.73e-06	4.8e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.69e-06	4.74e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PTEN—lung cancer	3.67e-06	4.71e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PIK3CB—lung cancer	3.63e-06	4.66e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.61e-06	4.64e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GNG11—lung cancer	3.61e-06	4.64e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PTGS2—lung cancer	3.59e-06	4.62e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GSTP1—lung cancer	3.56e-06	4.57e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PIK3CD—lung cancer	3.55e-06	4.57e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—STK11—lung cancer	3.54e-06	4.54e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—APOA1—lung cancer	3.52e-06	4.52e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—ALB—lung cancer	3.51e-06	4.51e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—STK11—lung cancer	3.51e-06	4.51e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—EP300—lung cancer	3.5e-06	4.49e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GSTP1—lung cancer	3.47e-06	4.46e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CAT—lung cancer	3.46e-06	4.45e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.44e-06	4.42e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—APOA1—lung cancer	3.44e-06	4.42e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ALDOA—lung cancer	3.44e-06	4.42e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CAT—lung cancer	3.38e-06	4.34e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—ABCB1—lung cancer	3.37e-06	4.33e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYP2E1—lung cancer	3.36e-06	4.32e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PIK3CB—lung cancer	3.36e-06	4.32e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—NCOA3—lung cancer	3.34e-06	4.29e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PIK3CB—lung cancer	3.33e-06	4.28e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PTGS2—lung cancer	3.33e-06	4.28e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—NQO1—lung cancer	3.32e-06	4.27e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—TYMS—lung cancer	3.31e-06	4.25e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PTGS2—lung cancer	3.3e-06	4.24e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.29e-06	4.23e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GSTP1—lung cancer	3.27e-06	4.2e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GSTM1—lung cancer	3.27e-06	4.2e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.25e-06	4.18e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ADCY1—lung cancer	3.25e-06	4.17e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ABCG2—lung cancer	3.25e-06	4.17e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GSTP1—lung cancer	3.24e-06	4.17e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—TYMS—lung cancer	3.23e-06	4.15e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.22e-06	4.14e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PIK3CG—lung cancer	3.21e-06	4.13e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GSTM1—lung cancer	3.19e-06	4.1e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CAT—lung cancer	3.18e-06	4.09e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ENO2—lung cancer	3.18e-06	4.09e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—HPGDS—lung cancer	3.18e-06	4.09e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PPP2R1B—lung cancer	3.16e-06	4.06e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CAT—lung cancer	3.16e-06	4.06e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PIK3CG—lung cancer	3.14e-06	4.04e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.14e-06	4.03e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PTEN—lung cancer	3.13e-06	4.03e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CYP1A1—lung cancer	3.1e-06	3.98e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PIK3CB—lung cancer	3.1e-06	3.98e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—ABCB1—lung cancer	3.1e-06	3.98e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GSTT1—lung cancer	3.09e-06	3.97e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—ERCC2—lung cancer	3.07e-06	3.95e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—ABCB1—lung cancer	3.07e-06	3.95e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PTGS2—lung cancer	3.07e-06	3.94e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—POMC—lung cancer	3.06e-06	3.93e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GCLC—lung cancer	3.05e-06	3.92e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP2A6—lung cancer	3.05e-06	3.92e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—TYMS—lung cancer	3.04e-06	3.91e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CYP1A1—lung cancer	3.03e-06	3.89e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—TYMS—lung cancer	3.02e-06	3.88e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GSTM1—lung cancer	3.01e-06	3.86e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—ERCC2—lung cancer	3e-06	3.86e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—STK11—lung cancer	3e-06	3.85e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—POMC—lung cancer	2.99e-06	3.84e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—EP300—lung cancer	2.99e-06	3.84e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GSTM1—lung cancer	2.98e-06	3.83e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CREBBP—lung cancer	2.98e-06	3.83e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CREBBP—lung cancer	2.91e-06	3.74e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PTEN—lung cancer	2.9e-06	3.73e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ENO1—lung cancer	2.89e-06	3.72e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PTEN—lung cancer	2.88e-06	3.7e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CYP1A1—lung cancer	2.85e-06	3.66e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—ERCC2—lung cancer	2.83e-06	3.63e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CYP1A1—lung cancer	2.83e-06	3.63e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PIK3CD—lung cancer	2.82e-06	3.63e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.81e-06	3.61e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—ERCC2—lung cancer	2.8e-06	3.6e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—ALB—lung cancer	2.79e-06	3.58e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GSTP1—lung cancer	2.77e-06	3.56e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—EP300—lung cancer	2.77e-06	3.56e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PIK3CD—lung cancer	2.76e-06	3.55e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—EP300—lung cancer	2.74e-06	3.52e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—ALB—lung cancer	2.73e-06	3.5e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CAT—lung cancer	2.7e-06	3.47e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.68e-06	3.45e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PTEN—lung cancer	2.68e-06	3.44e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—APOA1—lung cancer	2.66e-06	3.42e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ABCB1—lung cancer	2.62e-06	3.37e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—APOA1—lung cancer	2.6e-06	3.34e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP2E1—lung cancer	2.59e-06	3.33e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PIK3CA—lung cancer	2.59e-06	3.32e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—TYMS—lung cancer	2.58e-06	3.31e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—NQO1—lung cancer	2.57e-06	3.3e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—EP300—lung cancer	2.55e-06	3.28e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GSTM1—lung cancer	2.55e-06	3.27e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.55e-06	3.27e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PIK3CB—lung cancer	2.46e-06	3.16e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—APOA1—lung cancer	2.45e-06	3.14e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PTGS2—lung cancer	2.44e-06	3.13e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PIK3CG—lung cancer	2.43e-06	3.12e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—APOA1—lung cancer	2.42e-06	3.12e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYP1A1—lung cancer	2.42e-06	3.1e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PIK3CB—lung cancer	2.41e-06	3.09e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ERCC2—lung cancer	2.4e-06	3.08e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PTGS2—lung cancer	2.38e-06	3.06e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PIK3CG—lung cancer	2.37e-06	3.04e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.32e-06	2.98e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—STK11—lung cancer	2.31e-06	2.97e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—POMC—lung cancer	2.31e-06	2.97e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—POMC—lung cancer	2.26e-06	2.9e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CREBBP—lung cancer	2.25e-06	2.89e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PIK3CG—lung cancer	2.23e-06	2.87e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PIK3CG—lung cancer	2.21e-06	2.84e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PIK3CA—lung cancer	2.21e-06	2.84e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CREBBP—lung cancer	2.2e-06	2.82e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GSTP1—lung cancer	2.14e-06	2.75e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PIK3CD—lung cancer	2.13e-06	2.74e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PTEN—lung cancer	2.13e-06	2.73e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—POMC—lung cancer	2.13e-06	2.73e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—AKT1—lung cancer	2.11e-06	2.71e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—POMC—lung cancer	2.11e-06	2.71e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—ALB—lung cancer	2.11e-06	2.71e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PIK3CD—lung cancer	2.08e-06	2.68e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CAT—lung cancer	2.08e-06	2.68e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PTEN—lung cancer	2.08e-06	2.67e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—APOA1—lung cancer	2.07e-06	2.66e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CREBBP—lung cancer	2.07e-06	2.66e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—ALB—lung cancer	2.06e-06	2.64e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CREBBP—lung cancer	2.05e-06	2.64e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PIK3CA—lung cancer	2.05e-06	2.63e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PIK3CA—lung cancer	2.03e-06	2.61e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—EP300—lung cancer	2.03e-06	2.61e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ABCB1—lung cancer	2.03e-06	2.6e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—TYMS—lung cancer	1.99e-06	2.56e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.98e-06	2.55e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—EP300—lung cancer	1.98e-06	2.55e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GSTM1—lung cancer	1.97e-06	2.53e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PIK3CD—lung cancer	1.96e-06	2.52e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PIK3CD—lung cancer	1.95e-06	2.5e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—ALB—lung cancer	1.94e-06	2.49e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—ALB—lung cancer	1.92e-06	2.47e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PIK3CG—lung cancer	1.89e-06	2.43e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PIK3CA—lung cancer	1.89e-06	2.43e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP1A1—lung cancer	1.86e-06	2.4e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PIK3CB—lung cancer	1.86e-06	2.39e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ERCC2—lung cancer	1.85e-06	2.38e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PTGS2—lung cancer	1.84e-06	2.37e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PIK3CB—lung cancer	1.82e-06	2.33e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—AKT1—lung cancer	1.81e-06	2.32e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—POMC—lung cancer	1.8e-06	2.31e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PTGS2—lung cancer	1.8e-06	2.31e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CREBBP—lung cancer	1.75e-06	2.25e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PIK3CB—lung cancer	1.71e-06	2.2e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PIK3CB—lung cancer	1.7e-06	2.18e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PTGS2—lung cancer	1.7e-06	2.18e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PTGS2—lung cancer	1.68e-06	2.16e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—AKT1—lung cancer	1.67e-06	2.15e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PIK3CD—lung cancer	1.66e-06	2.14e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—AKT1—lung cancer	1.66e-06	2.13e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ALB—lung cancer	1.64e-06	2.11e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PTEN—lung cancer	1.61e-06	2.07e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—APOA1—lung cancer	1.6e-06	2.05e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PTEN—lung cancer	1.57e-06	2.02e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—AKT1—lung cancer	1.54e-06	1.98e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—EP300—lung cancer	1.53e-06	1.97e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PIK3CA—lung cancer	1.5e-06	1.93e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—EP300—lung cancer	1.5e-06	1.92e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PTEN—lung cancer	1.48e-06	1.9e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PIK3CA—lung cancer	1.47e-06	1.88e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PTEN—lung cancer	1.47e-06	1.88e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PIK3CG—lung cancer	1.46e-06	1.88e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PIK3CB—lung cancer	1.45e-06	1.86e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PTGS2—lung cancer	1.44e-06	1.85e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—EP300—lung cancer	1.41e-06	1.81e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—EP300—lung cancer	1.4e-06	1.8e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—POMC—lung cancer	1.39e-06	1.79e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CREBBP—lung cancer	1.35e-06	1.74e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PIK3CD—lung cancer	1.28e-06	1.65e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ALB—lung cancer	1.27e-06	1.63e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PTEN—lung cancer	1.25e-06	1.61e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—AKT1—lung cancer	1.23e-06	1.58e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—AKT1—lung cancer	1.2e-06	1.54e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—EP300—lung cancer	1.19e-06	1.53e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PIK3CA—lung cancer	1.13e-06	1.46e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PIK3CB—lung cancer	1.12e-06	1.44e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PTGS2—lung cancer	1.11e-06	1.42e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PIK3CA—lung cancer	1.11e-06	1.42e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PIK3CA—lung cancer	1.04e-06	1.34e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PIK3CA—lung cancer	1.03e-06	1.33e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PTEN—lung cancer	9.67e-07	1.24e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—AKT1—lung cancer	9.26e-07	1.19e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—EP300—lung cancer	9.22e-07	1.18e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—AKT1—lung cancer	9.04e-07	1.16e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PIK3CA—lung cancer	8.84e-07	1.14e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—AKT1—lung cancer	8.52e-07	1.09e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—AKT1—lung cancer	8.45e-07	1.09e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—AKT1—lung cancer	7.22e-07	9.28e-06	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PIK3CA—lung cancer	6.82e-07	8.76e-06	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—AKT1—lung cancer	5.57e-07	7.16e-06	CbGpPWpGaD
